Cargando…

Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial

INTRODUCTION: Alcohol use disorders (AUDs) and mood disorders commonly co-occur, and are associated with a range of negative outcomes for patients. Mobile phone technology has the potential to provide personalised support for such patients and potentially improve outcomes in this difficult-to-treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartnett, Dan, Murphy, Edel, Kehoe, Elizabeth, Agyapong, Vincent, McLoughlin, Declan M, Farren, Conor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729994/
https://www.ncbi.nlm.nih.gov/pubmed/28554910
http://dx.doi.org/10.1136/bmjopen-2016-013587
_version_ 1783286280785756160
author Hartnett, Dan
Murphy, Edel
Kehoe, Elizabeth
Agyapong, Vincent
McLoughlin, Declan M
Farren, Conor
author_facet Hartnett, Dan
Murphy, Edel
Kehoe, Elizabeth
Agyapong, Vincent
McLoughlin, Declan M
Farren, Conor
author_sort Hartnett, Dan
collection PubMed
description INTRODUCTION: Alcohol use disorders (AUDs) and mood disorders commonly co-occur, and are associated with a range of negative outcomes for patients. Mobile phone technology has the potential to provide personalised support for such patients and potentially improve outcomes in this difficult-to-treat cohort. The aim of this study is to examine whether receiving supporting SMS text messages, following discharge from an inpatient dual diagnosis treatment programme, has a positive impact on mood and alcohol abstinence in patients with an AUD and a comorbid mood disorder. METHODS AND ANALYSIS: The present study is a single-blind randomised controlled trial. Patients aged 18–70 years who meet the criteria for both alcohol dependency syndrome/alcohol abuse and either major depressive disorder or bipolar disorder according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV Axis I will be randomised to receive twice-daily supportive SMS text messages for 6 months plus treatment as usual, or treatment as usual alone, and will be followed-up at 3, 6, 9 and 12 months postdischarge. Primary outcome measures will include changes from baseline in cumulative abstinence duration, which will be expressed as the proportion of days abstinent from alcohol in the preceding 90 days, and changes from baseline in Beck Depression Inventory scores. ETHICS AND DISSEMINATION: The trial has received full ethical approval from the St. Patrick’s Hospital Research Ethics Committee (protocol 13/14). Results of the trial will be disseminated through peer-reviewed journal articles and at academic conferences. TRIAL REGISTRATION NUMBER: NCT02404662; Pre-results.
format Online
Article
Text
id pubmed-5729994
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-57299942017-12-19 Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial Hartnett, Dan Murphy, Edel Kehoe, Elizabeth Agyapong, Vincent McLoughlin, Declan M Farren, Conor BMJ Open Addiction INTRODUCTION: Alcohol use disorders (AUDs) and mood disorders commonly co-occur, and are associated with a range of negative outcomes for patients. Mobile phone technology has the potential to provide personalised support for such patients and potentially improve outcomes in this difficult-to-treat cohort. The aim of this study is to examine whether receiving supporting SMS text messages, following discharge from an inpatient dual diagnosis treatment programme, has a positive impact on mood and alcohol abstinence in patients with an AUD and a comorbid mood disorder. METHODS AND ANALYSIS: The present study is a single-blind randomised controlled trial. Patients aged 18–70 years who meet the criteria for both alcohol dependency syndrome/alcohol abuse and either major depressive disorder or bipolar disorder according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders IV Axis I will be randomised to receive twice-daily supportive SMS text messages for 6 months plus treatment as usual, or treatment as usual alone, and will be followed-up at 3, 6, 9 and 12 months postdischarge. Primary outcome measures will include changes from baseline in cumulative abstinence duration, which will be expressed as the proportion of days abstinent from alcohol in the preceding 90 days, and changes from baseline in Beck Depression Inventory scores. ETHICS AND DISSEMINATION: The trial has received full ethical approval from the St. Patrick’s Hospital Research Ethics Committee (protocol 13/14). Results of the trial will be disseminated through peer-reviewed journal articles and at academic conferences. TRIAL REGISTRATION NUMBER: NCT02404662; Pre-results. BMJ Publishing Group 2017-05-29 /pmc/articles/PMC5729994/ /pubmed/28554910 http://dx.doi.org/10.1136/bmjopen-2016-013587 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Addiction
Hartnett, Dan
Murphy, Edel
Kehoe, Elizabeth
Agyapong, Vincent
McLoughlin, Declan M
Farren, Conor
Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title_full Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title_fullStr Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title_full_unstemmed Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title_short Supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
title_sort supportive text messages for patients with alcohol use disorder and a comorbid depression: a protocol for a single-blind randomised controlled aftercare trial
topic Addiction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729994/
https://www.ncbi.nlm.nih.gov/pubmed/28554910
http://dx.doi.org/10.1136/bmjopen-2016-013587
work_keys_str_mv AT hartnettdan supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial
AT murphyedel supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial
AT kehoeelizabeth supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial
AT agyapongvincent supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial
AT mcloughlindeclanm supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial
AT farrenconor supportivetextmessagesforpatientswithalcoholusedisorderandacomorbiddepressionaprotocolforasingleblindrandomisedcontrolledaftercaretrial